OBJECTIVE: To compare CSF levels of beta-amyloid 1–42 (Aβ 1–42 ), total tau (tau) and tau
phosphorylated at threonine 181 (ptau-181) between AD patients and controls according to …

In this longitudinal study we investigated change over time in cerebrospinal fluid (CSF)
levels of amyloid-beta 40 and 42 (Aβ40 and Aβ42), total tau (tau), tau phosphorylated at …

Most patients with Alzheimer's disease present with amnestic problems; however, a substantial
proportion, over-represented in young-onset cases, have atypical phenotypes including …

Background: To improve ante mortem diagnostic accuracy of Alzheimer disease (AD),
measurement of the biomarkers amyloid-β(1–42) (Aβ42), total tau (Tau), and tau phosphorylated …

Since its opening in 2000, patient care and research go hand in hand at the Alzheimer
center of the VU University Medical Center, both organized in such a way that they mutually …

Background We aimed to identify the most useful definition of the “cerebrospinal fluid Alzheimer
profile,” based on amyloid-ß 1-42 (Aβ 42 ), total tau, and phosphorylated tau (p-tau), for …

Background Immunoreactivity for several chemokines and for their related receptors has
been demonstrated in resident cells of the central nervous system, and the up-regulation of …

Introduction Retinal characteristics are increasingly recognized as biomarkers for
neurodegenerative diseases. Retinal thickness measured by optical coherence tomography may …

Accurately distinguishing between different degenerative dementias during life is challenging
but increasingly important with the prospect of disease-modifying therapies. Molecular …

Importance It remains unclear if and how associations between cerebral small-vessel disease
and Alzheimer disease (AD) pathology lead to cognitive decline and dementia. Objective …